Cancer Biomarker Research and Personalized Medicine
Biomarkers are measures of a biological state. The treatment of individual patients based on particular factors, such as biomarkers, distinguishes standard, generalized treatment plans from personalized medicine. Even though personalized medicine is applicable to most branches of medicine, the field...
Saved in:
| Sonstige: | |
|---|---|
| Year of Publication: | 2022 |
| Language: | English |
| Physical Description: | 1 electronic resource (428 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
993600375204498 |
|---|---|
| ctrlnum |
(CKB)5680000000037538 (oapen)https://directory.doabooks.org/handle/20.500.12854/81000 (EXLCZ)995680000000037538 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Meehan, James edt Cancer Biomarker Research and Personalized Medicine Basel MDPI - Multidisciplinary Digital Publishing Institute 2022 1 electronic resource (428 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Biomarkers are measures of a biological state. The treatment of individual patients based on particular factors, such as biomarkers, distinguishes standard, generalized treatment plans from personalized medicine. Even though personalized medicine is applicable to most branches of medicine, the field of oncology is perhaps where it is most easily employed. Cancer is a heterogeneous disease; although patients may be diagnosed histologically with the same cancer type, their tumors can comprise varying tumor microenvironments and molecular characteristics that can impact treatment response and prognosis. There has been a major drive over the past decade to try and realize personalized cancer medicine through the discovery and use of disease-specific biomarkers. This book, entitled “Cancer Biomarker Research and Personalized Medicine”, encompasses 22 publications from colleagues working on a diverse range of cancers, including prostate, breast, ovarian, head and neck, liver, gastric, bladder, colorectal, and kidney. The biomarkers assessed in these studies include genes, intracellular or secreted proteins, exosomes, DNA, RNA, miRNA, circulating tumor cells, circulating immune cells, in addition to radiomic features. English Medicine bicssc Oncology bicssc clear cell renal cell carcinoma radiomics WHO/ISUP nuclear grade multiphasic multidetector computed tomography triple-negative breast cancer taxane chemotherapy GBP5 Akt/mTOR autophagy IL13Rα2 renal cell carcinoma JAK2 FOXO3 telmisartan ovarian cancer bioinformatics CREB1 drug perturbation lincRNA-p21 rectal cancer chemoradiotherapy colorectal cancer long non-coding RNA p53 predictive biomarker intestinal anastomosis anastomotic leak biomarkers precision medicine personalized medicine biomarker AmpliSeq DNA methylation epigenetics head and neck cancer saliva liquid biopsy meta-analysis gastric cancer middle-up-down haptoglobin glycopeptide mass spectrometry circulating tumor cells prostate cancer cancer vaccine immune response breast cancer predictive tools prognostic tools translational research IL6ST gp130 cytokine signalling tissue-based biomarkers liquid-based biomarkers radiotherapy radiosensitivity biomarkers secretome radioresistance bladder tumor lymphocyte-to-monocyte ratio peripheral blood parameters tumor recurrence transurethral resection lipidomics 1H-NMR LC-MS/MS lipoprotein subfractions lipoprotein lipase cancer biomarkers hepatocellular carcinoma p16 expression head and neck squamous cell carcinoma HPV genotyping exosomes chemoresistance comparative oncology One Health microRNA lymph node metastasis hormone-dependent carcinogenesis localized prostate cancer prognostic factors HNSCC 3-0365-3918-2 3-0365-3917-4 Meehan, James oth |
| language |
English |
| format |
eBook |
| author2 |
Meehan, James |
| author_facet |
Meehan, James |
| author2_variant |
j m jm |
| author2_role |
Sonstige |
| title |
Cancer Biomarker Research and Personalized Medicine |
| spellingShingle |
Cancer Biomarker Research and Personalized Medicine |
| title_full |
Cancer Biomarker Research and Personalized Medicine |
| title_fullStr |
Cancer Biomarker Research and Personalized Medicine |
| title_full_unstemmed |
Cancer Biomarker Research and Personalized Medicine |
| title_auth |
Cancer Biomarker Research and Personalized Medicine |
| title_new |
Cancer Biomarker Research and Personalized Medicine |
| title_sort |
cancer biomarker research and personalized medicine |
| publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
| publishDate |
2022 |
| physical |
1 electronic resource (428 p.) |
| isbn |
3-0365-3918-2 3-0365-3917-4 |
| illustrated |
Not Illustrated |
| work_keys_str_mv |
AT meehanjames cancerbiomarkerresearchandpersonalizedmedicine |
| status_str |
n |
| ids_txt_mv |
(CKB)5680000000037538 (oapen)https://directory.doabooks.org/handle/20.500.12854/81000 (EXLCZ)995680000000037538 |
| carrierType_str_mv |
cr |
| is_hierarchy_title |
Cancer Biomarker Research and Personalized Medicine |
| author2_original_writing_str_mv |
noLinkedField |
| _version_ |
1796653168995598336 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04963nam-a2201333z--4500</leader><controlfield tag="001">993600375204498</controlfield><controlfield tag="005">20231214132952.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202205s2022 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5680000000037538</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/81000</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995680000000037538</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Meehan, James</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cancer Biomarker Research and Personalized Medicine</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (428 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Biomarkers are measures of a biological state. The treatment of individual patients based on particular factors, such as biomarkers, distinguishes standard, generalized treatment plans from personalized medicine. Even though personalized medicine is applicable to most branches of medicine, the field of oncology is perhaps where it is most easily employed. Cancer is a heterogeneous disease; although patients may be diagnosed histologically with the same cancer type, their tumors can comprise varying tumor microenvironments and molecular characteristics that can impact treatment response and prognosis. There has been a major drive over the past decade to try and realize personalized cancer medicine through the discovery and use of disease-specific biomarkers. This book, entitled “Cancer Biomarker Research and Personalized Medicine”, encompasses 22 publications from colleagues working on a diverse range of cancers, including prostate, breast, ovarian, head and neck, liver, gastric, bladder, colorectal, and kidney. The biomarkers assessed in these studies include genes, intracellular or secreted proteins, exosomes, DNA, RNA, miRNA, circulating tumor cells, circulating immune cells, in addition to radiomic features.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oncology</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clear cell renal cell carcinoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radiomics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">WHO/ISUP nuclear grade</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multiphasic multidetector computed tomography</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">triple-negative breast cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">taxane</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chemotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">GBP5</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Akt/mTOR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">autophagy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">IL13Rα2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">renal cell carcinoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">JAK2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FOXO3</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">telmisartan</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ovarian cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bioinformatics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CREB1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug perturbation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lincRNA-p21</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rectal cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chemoradiotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">colorectal cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">long non-coding RNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">p53</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">predictive biomarker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">intestinal anastomosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anastomotic leak</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biomarkers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">precision medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">personalized medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biomarker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">AmpliSeq</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">DNA methylation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epigenetics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">head and neck cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">saliva</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">liquid biopsy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">meta-analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gastric cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">middle-up-down</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">haptoglobin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glycopeptide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mass spectrometry</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">circulating tumor cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prostate cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer vaccine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune response</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">breast cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">predictive tools</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prognostic tools</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">translational research</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">IL6ST</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gp130</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cytokine signalling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tissue-based biomarkers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">liquid-based biomarkers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radiotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radiosensitivity biomarkers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">secretome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radioresistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bladder tumor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lymphocyte-to-monocyte ratio</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">peripheral blood parameters</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor recurrence</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">transurethral resection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lipidomics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">1H-NMR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">LC-MS/MS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lipoprotein subfractions</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lipoprotein lipase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer biomarkers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hepatocellular carcinoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">p16 expression</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">head and neck squamous cell carcinoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HPV genotyping</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">exosomes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chemoresistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">comparative oncology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">One Health</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microRNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lymph node metastasis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hormone-dependent carcinogenesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">localized prostate cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prognostic factors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HNSCC</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-3918-2</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-3917-4</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Meehan, James</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:38:35 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-05-14 21:41:54 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5345742530004498&Force_direct=true</subfield><subfield code="Z">5345742530004498</subfield><subfield code="b">Available</subfield><subfield code="8">5345742530004498</subfield></datafield></record></collection> |